Chief Medical Officer Summit
April 4 - 5, 2019 - Boston MA USChief Medical Officer Summit
service@tcfllc.org
Phone:6463502580
We are pleased to welcome Dr Julie Krop, CMO, EVP, Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals, Dr Zain Kassam, Co-Founder, EVP, Clinical Development and Translational Medicine, Finch Therapeutics and Dr Steven Zelenkofske, EVP, CMO, Achillion Pharmaceuticals as co-chairs for the 2019 CMO Summit. Dr Zelenkofske helped launch the first CMO Summit, Dr Krop is returning for the second year and Dr Kassam is joining the leadership for the first time. Joining the Summit for the first time are Dr Steve Kanes, CMO, Sage Therapeutics, who shares his experience on navigating a new indication through the FDA as a young company, and Dr Bernie Zeiher, CMO and President, Development, Astellas Pharma with large pharma perspectives. Annual keynote speaker Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, is confirmed to provide his drug development zeitgeist talk. This conference is dedicated to accomplishing two goals: 1) To bring together CMO and RandD executives to address the unique challenges associated with directing and managing all RandD functions with limited resources, while raising capital and strategizing for appropriate exits. 2) To create a network of CMOs and RandD Leadership from small to mid-size life science companies to share ideas, solutions and support. Key Topic Areas for 2019 Talent Gap in Biotech – Next steps Designing Clinical Trials for Gene Therapy – a Paradigm Shift Unique Development Challenges in the Microbiome Immuno-Oncology: When and How to Approach Strategic Collaborations and Partnerships How to De-Risk a Development Program from a Regulatory Perspective Best Practices for Preparing for Investors Going from Big Pharma to Small Biotech Leadership: Challenges and Opportunities How to Navigate the Development Path from CMO to CEO Mechanisms for CMO Performance Improvement